The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.
作者信息
Chun Stephen G, Solberg Timothy D, Grosshans David R, Nguyen Quynh-Nhu, Simone Charles B, Mohan Radhe, Liao Zhongxing, Hahn Stephen M, Herman Joseph M, Frank Steven J
机构信息
Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, United States.
出版信息
Front Oncol. 2017 Sep 5;7:201. doi: 10.3389/fonc.2017.00201. eCollection 2017.
Abstract
摘要
相似文献
1
The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.
Front Oncol. 2017 Sep 5;7:201. doi: 10.3389/fonc.2017.00201. eCollection 2017.
2
Overview of clinical experiences on carbon ion radiotherapy at NIRS.
Radiother Oncol. 2004 Dec;73 Suppl 2:S41-9. doi: 10.1016/s0167-8140(04)80012-4.
3
Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Radiat Oncol. 2017 May 30;12(1):91. doi: 10.1186/s13014-017-0830-z.
4
[Heavy ion therapy for non-small cell lung cancer--new, radical radiotherapy for advanced-age patients as an alternative to surgery].
Gan To Kagaku Ryoho. 2003 Feb;30(2):209-14.
5
[Heavy-ion therapy for non-small cell lung cancer].
Nihon Geka Gakkai Zasshi. 2002 Feb;103(2):250-5.
6
A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
Cancer. 2015 Apr 15;121(8):1321-7. doi: 10.1002/cncr.29195. Epub 2015 Jan 13.
7
Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
PLoS One. 2017 Apr 11;12(4):e0175589. doi: 10.1371/journal.pone.0175589. eCollection 2017.
8
Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction).
Radiol Med. 2019 Dec;124(12):1324-1332. doi: 10.1007/s11547-019-01064-2. Epub 2019 Jul 17.
9
Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up.
Radiat Oncol. 2019 Jun 24;14(1):112. doi: 10.1186/s13014-019-1317-x.
10
Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer.
Ann Oncol. 2016 Apr;27(4):590-9. doi: 10.1093/annonc/mdv621. Epub 2015 Dec 27.
引用本文的文献
1
Accelerated Hypofractionated Radiotherapy for Locally Advanced NSCLC: A Systematic Review From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee.
J Thorac Oncol. 2025 Jan;20(1):39-51. doi: 10.1016/j.jtho.2024.09.1437. Epub 2024 Sep 28.
2
Research Progress of Heavy Ion Radiotherapy for Non-Small-Cell Lung Cancer.
Int J Mol Sci. 2022 Feb 19;23(4):2316. doi: 10.3390/ijms23042316.
3
Anthropomorphic lung phantom based validation of in-room proton therapy 4D-CBCT image correction for dose calculation.
Z Med Phys. 2022 Feb;32(1):74-84. doi: 10.1016/j.zemedi.2020.09.004. Epub 2020 Nov 25.
4
Dosimetric evaluation of 4D-CBCT reconstructed by Simultaneous Motion Estimation and Image Reconstruction (SMEIR) for carbon ion therapy of lung cancer.
Med Phys. 2019 Sep;46(9):4087-4094. doi: 10.1002/mp.13706. Epub 2019 Jul 31.
5
Effects of crystallographic and geometric orientation on ion beam sputtering of gold nanorods.
Sci Rep. 2018 Jan 11;8(1):512. doi: 10.1038/s41598-017-17424-9.
本文引用的文献
1
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.
Ann Oncol. 2017 May 1;28(5):1084-1089. doi: 10.1093/annonc/mdx069.
2
Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
PLoS One. 2017 Apr 11;12(4):e0175589. doi: 10.1371/journal.pone.0175589. eCollection 2017.
3
Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol. 2017 May 1;35(13):1395-1402. doi: 10.1200/JCO.2016.71.6142. Epub 2017 Mar 16.
4
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
J Clin Oncol. 2017 May 1;35(13):1387-1394. doi: 10.1200/JCO.2016.70.0229. Epub 2017 Jan 23.
5
Reply to D. Ball et al.
J Clin Oncol. 2017 May 1;35(13):1493-1494. doi: 10.1200/JCO.2016.71.5755. Epub 2017 Jan 9.
6
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
J Clin Oncol. 2017 Jan;35(1):56-62. doi: 10.1200/JCO.2016.69.1378. Epub 2016 Oct 31.
7
Does Heavy Ion Therapy Work Through the Immune System?
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):934-936. doi: 10.1016/j.ijrobp.2016.08.037. Epub 2016 Sep 5.
8
Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non-small cell lung cancer.
J Radiat Res. 2016 Sep;57(5):548-554. doi: 10.1093/jrr/rrw041. Epub 2016 May 29.
9
Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation.
Radiother Oncol. 2016 Jun;119(3):495-500. doi: 10.1016/j.radonc.2016.04.025. Epub 2016 May 14.
10
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
JAMA Oncol. 2016 Mar;2(3):359-67. doi: 10.1001/jamaoncol.2015.3969.
Zotero 插件